Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes (Q34635314)

3 August 2017

1 reference

title

Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes (English)

1 reference

3 August 2017

1 reference

Tiu R

1

1 reference

3 August 2017

Gondek L

series ordinal

2

1 reference

3 August 2017

O'Keefe C

series ordinal

3

1 reference

3 August 2017

Maciejewski JP

series ordinal

4

1 reference

3 August 2017

publication date

7 June 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

21

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

1648-1657

1 reference

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

Whole genome DNA copy number changes identified by high density oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

Current concepts in the pathophysiology and treatment of aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?"

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Evolution of clonal cytogenetic abnormalities in aplastic anemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Clonality in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Hematopoietic stem cells in aplastic anemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Antithymocyte globulin for patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Telomere length in leukocyte subpopulations of patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Involvement and functional impairment of the CD34( )CD38(-)Thy-1( ) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2'-deoxycytidine (decitabine).

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Recent advances in telomere biology: implications for human cancer.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Pot1, the putative telomere end-binding protein in fission yeast and humans

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

POT1 as a terminal transducer of TRF1 telomere length control

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Telomerase activity in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Chromosome and molecular abnormalities in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Combination of classical and interphase cytogenetics to investigate the biology of myeloid disorders: detection of masked monosomy 7 in AML

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Molecular karyotyping using an SNP array for genomewide genotyping.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies wit

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

High-resolution analysis of DNA copy number using oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Genome-wide aberrations in pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Paracentric inversion of chromosome 3 (q21q26) in a patient with chronic myelomonocytic leukemia and a normal platelet count

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2404757

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404757

1 reference

Dimensions Publication ID

3 August 2017

1032458552

0 references

1 reference